RNA Therapeutics Core launches at Mass General Brigham to boost circular RNA research

Less than 14 months af­ter be­com­ing a stand­alone com­pa­ny, John­son & John­son’s con­sumer health­care spin­out Ken­vue is star­ing down an ac­tivist in­vestor. The in­vestor, Star­board

Despite a difficult investing environment, major well-capitalised contract manufacturing organisations (CMOs) have been involved in recent acquisitions, as big pharma and private equity alike highly value